These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 37824705)
1. Foldback-crRNA-Enhanced CRISPR/Cas13a System (FCECas13a) Enables Direct Detection of Ultrashort sncRNA. Chen Y; Zhang Y; Luo S; Yang X; Liu C; Zhang Q; Liu Y; Zhang X Anal Chem; 2023 Oct; 95(42):15606-15613. PubMed ID: 37824705 [TBL] [Abstract][Full Text] [Related]
2. Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme. Knott GJ; East-Seletsky A; Cofsky JC; Holton JM; Charles E; O'Connell MR; Doudna JA Nat Struct Mol Biol; 2017 Oct; 24(10):825-833. PubMed ID: 28892041 [TBL] [Abstract][Full Text] [Related]
3. Specific High-Sensitivity Enzymatic Molecular Detection System Termed RPA-Based CRISPR-Cas13a for Duck Tembusu Virus Diagnostics. He D; Liu G; Yang J; Jiang X; Wang H; Fan Y; Gong S; Wei F; Diao Y; Tang Y Bioconjug Chem; 2022 Jun; 33(6):1232-1240. PubMed ID: 35586918 [TBL] [Abstract][Full Text] [Related]
5. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a. Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251 [TBL] [Abstract][Full Text] [Related]
6. Programming the Liu X; Kang X; Lei C; Ren W; Liu C Anal Chem; 2022 Mar; 94(9):3987-3996. PubMed ID: 35193353 [TBL] [Abstract][Full Text] [Related]
7. Improving trans-cleavage activity of CRISPR-Cas13a using engineered crRNA with a uridinylate-rich 5'-overhang. Yang Y; Sun L; Zhao J; Jiao Y; Han T; Zhou X Biosens Bioelectron; 2024 Jul; 255():116239. PubMed ID: 38552526 [TBL] [Abstract][Full Text] [Related]
8. High-Fidelity and Rapid Quantification of miRNA Combining crRNA Programmability and CRISPR/Cas13a trans-Cleavage Activity. Shan Y; Zhou X; Huang R; Xing D Anal Chem; 2019 Apr; 91(8):5278-5285. PubMed ID: 30873832 [TBL] [Abstract][Full Text] [Related]
9. A rapid and efficient platform for antiviral crRNA screening using CRISPR-Cas13a-based nucleic acid detection. Yang L; Zhang Y; Yi W; Dong X; Niu M; Song Y; Han Y; Li H; Sun Y Front Immunol; 2023; 14():1116230. PubMed ID: 37228594 [TBL] [Abstract][Full Text] [Related]
10. A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity. Meeske AJ; Jia N; Cassel AK; Kozlova A; Liao J; Wiedmann M; Patel DJ; Marraffini LA Science; 2020 Jul; 369(6499):54-59. PubMed ID: 32467331 [TBL] [Abstract][Full Text] [Related]
11. Universal theranostic CRISPR/Cas13a RNA-editing system for glioma. Wu Y; Wang Y; Zhou J; Wang J; Zhan Q; Wang Q; Yang E; Jin W; Tong F; Zhao J; Hong B; Liu J; Kang C Theranostics; 2023; 13(15):5305-5321. PubMed ID: 37908718 [No Abstract] [Full Text] [Related]
12. Tetrahedron supported CRISPR/Cas13a cleavage for electrochemical detection of circular RNA in bladder cancer. Cheng L; Yang F; Zhao Y; Liu Z; Yao X; Zhang J Biosens Bioelectron; 2023 Feb; 222():114982. PubMed ID: 36493719 [TBL] [Abstract][Full Text] [Related]
13. Electrochemical biosensor for nucleic acid amplification-free and sensitive detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA via CRISPR/Cas13a trans-cleavage reaction. Heo W; Lee K; Park S; Hyun KA; Jung HI Biosens Bioelectron; 2022 Apr; 201():113960. PubMed ID: 35016109 [TBL] [Abstract][Full Text] [Related]
14. The CRISPR-Cas13a Gemini System for noncontiguous target RNA activation. Zhao H; Sheng Y; Zhang T; Zhou S; Zhu Y; Qian F; Liu M; Xu W; Zhang D; Hu J Nat Commun; 2024 Apr; 15(1):2901. PubMed ID: 38575571 [TBL] [Abstract][Full Text] [Related]
15. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1. Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081 [TBL] [Abstract][Full Text] [Related]
16. Target-induced transcription amplification to trigger the trans-cleavage activity of CRISPR/Cas13a (TITAC-Cas) for detection of alkaline phosphatase. Wang X; Zhou S; Chu C; Yang M; Huo D; Hou C Biosens Bioelectron; 2021 Aug; 185():113281. PubMed ID: 33940494 [TBL] [Abstract][Full Text] [Related]
18. Hierarchical self-uncloaking CRISPR-Cas13a-customized RNA nanococoons for spatial-controlled genome editing and precise cancer therapy. Fan N; Bian X; Li M; Chen J; Wu H; Peng Q; Bai H; Cheng W; Kong L; Ding S; Li S; Cheng W Sci Adv; 2022 May; 8(20):eabn7382. PubMed ID: 35584220 [TBL] [Abstract][Full Text] [Related]
19. Massively parallel profiling of RNA-targeting CRISPR-Cas13d. Kuo HC; Prupes J; Chou CW; Finkelstein IJ Nat Commun; 2024 Jan; 15(1):498. PubMed ID: 38216559 [TBL] [Abstract][Full Text] [Related]
20. Dual Methylation-Sensitive Restriction Endonucleases Coupling with an RPA-Assisted CRISPR/Cas13a System (DESCS) for Highly Sensitive Analysis of DNA Methylation and Its Application for Point-of-Care Detection. Wang X; Zhou S; Chu C; Yang M; Huo D; Hou C ACS Sens; 2021 Jun; 6(6):2419-2428. PubMed ID: 34019391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]